These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18616207)

  • 1. [Systemic treatment of metastatic colorectal cancer].
    Montemurro M; Achtari L; Röth A; Halkic N; Luthi F; Ozsahin M; Denys A; Bauer J; Demartines N; Leyvraz S
    Rev Med Suisse; 2008 May; 4(158):1254-7. PubMed ID: 18616207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy for metastatic colorectal cancer].
    Iwasa S; Shimada Y
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
    Sabharwal A; Kerr D
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):477-87. PubMed ID: 17428169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer.
    Jain VK; Hawkes EA; Cunningham D
    Clin Colorectal Cancer; 2011 Dec; 10(4):245-57. PubMed ID: 21729675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
    Wadhawan A; Stephens R; Adams R
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for colorectal cancer liver metastases.
    Alberts SR; Wagman LD
    Oncologist; 2008 Oct; 13(10):1063-73. PubMed ID: 18838438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies.
    Saif MW; Kang SP; Chu E
    Oncology (Williston Park); 2006 Dec; 20(14 Suppl 10):11-9. PubMed ID: 17354513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
    Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer.
    Lucas AS; O'Neil BH; Goldberg RM
    Clin Colorectal Cancer; 2011 Dec; 10(4):238-44. PubMed ID: 21820973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Second-line chemotherapy for colorectal cancer].
    Komatsu Y; Sogabe S; Kawamoto Y; Iwanaga I; Uehata Y; Yuki S; Asaka M
    Gan To Kagaku Ryoho; 2009 May; 36(5):721-5. PubMed ID: 19461170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatment of patients who have colorectal cancer and inflammatory bowel disease.
    Goessling W; Mayer RJ
    Gastroenterol Clin North Am; 2006 Sep; 35(3):713-27. PubMed ID: 16952747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated options for liver-limited metastatic colorectal cancer.
    Alberts SR
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S58-62. PubMed ID: 19064408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of salvage treatment in advanced colorectal cancer.
    Capdevila J; Ramos FJ; Macarulla T; Elez E; Tabernero J
    Crit Rev Oncol Hematol; 2009 Jul; 71(1):53-61. PubMed ID: 18977669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008.
    Price TJ; Tebbutt NC; Karapetis CS; Segelov E; Pavlakis N; Cunningham D; Sobrero AF; Haller DG; Shapiro JD
    Clin Colorectal Cancer; 2010 Jan; 9(1):8-14. PubMed ID: 20100683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction: Advances in treatment of metastatic colorectal cancer.
    Folprecht G
    Cancer Treat Rev; 2008; 34 Suppl 2():S1-2. PubMed ID: 19101402
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancer.
    Arkenau HT; Brunetto AT; Barriuso J; Olmos D; Eaton D; de Bono J; Judson I; Kaye S
    Oncology; 2009; 76(3):151-6. PubMed ID: 19169046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of UFT in metastatic colorectal cancer.
    Bennouna J; Saunders M; Douillard JY
    Oncology; 2009; 76(5):301-10. PubMed ID: 19299903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.